Brendan P. O'Grady
EVP, North America Commercial, Teva Pharmaceutical Industries Ltd.
Companies
- Nasus Pharma LtdBoard member Jul 31, 2026 to now1
- Nasus Pharma LtdChief executive officer Jul 31, 2026 to now1
- Assertio Holdings, Inc.Board member Jun 4, 2024 to now2
- Assertio Holdings, Inc.Chief executive officer Jun 4, 2024 to Nov 14, 20252
- Teva Pharmaceutical Industries Ltd.EVP, North America Commercial Jan 2, 2018 to Mar 8, 20213
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Assertio Holdings, Inc.128,955 shares4May 31, 2025
As of each latest filing. The line shows shares held over time.
Recent filings
- May 31, 2025Shares withheld for tax 49,416 shares at $0.66 of Assertio Holdings, Inc.4
- May 31, 2025Exercised options 166,665 shares of Assertio Holdings, Inc.4
- Nov 14, 2024Bought 11,706 shares at $0.85 of Assertio Holdings, Inc.5
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARNasus Pharma Ltd, Board member
- 2
- 3
- 4
- 5SEC EDGARForm 4 filed Nov 15, 2024